128 related articles for article (PubMed ID: 6048655)
1. Cycloserine plus ethionamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
Ramakrishnan CV; Devadatta S; Evans C; Kamat SR; Menon NK; Radhakrishna S; Rajagopalan S; Stott H; Tripathy SP; Velu S
Tubercle; 1967 Jun; 48(2):114-27. PubMed ID: 6048655
[No Abstract] [Full Text] [Related]
2. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
[No Abstract] [Full Text] [Related]
3. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
Bartal M; Nejjar A; Laraki A
Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
[No Abstract] [Full Text] [Related]
4. The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up.
Tousek J; Jancik E; Zelenka M; Jancikova-Máková M
Tubercle; 1967 Mar; 48(1):27-31. PubMed ID: 4291925
[No Abstract] [Full Text] [Related]
5. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
Rudoĭ NM; Utkin VV; Fedorova IE; Afanas'eva IuP
Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
[No Abstract] [Full Text] [Related]
6. Late results in re-treatment of patients with pulmonary tuberculosis.
Zierski M; Zachara A
Tubercle; 1970 Jun; 51(2):172-7. PubMed ID: 5493744
[No Abstract] [Full Text] [Related]
7. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
Narang RK; Singh SK
Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
[No Abstract] [Full Text] [Related]
8. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
Bignall JR; Lind A; Rist N
Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
[No Abstract] [Full Text] [Related]
9. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis].
Srednicka-Zajac D; Mysakowska H; Szarewicz-Adamczyk W; Litwin B
Ann Univ Mariae Curie Sklodowska Med; 1967; 22():71-8. PubMed ID: 4308440
[No Abstract] [Full Text] [Related]
10. Late results of treatment of chronic drug-resistant pulmonary tuberculosis.
Somner AR; Brace AA
Br Med J; 1966 Mar; 1(5490):775-8. PubMed ID: 5910108
[No Abstract] [Full Text] [Related]
11. Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Somner AR; Selkon JB; Walton M; White AB
Tubercle; 1971 Dec; 52(4):266-75. PubMed ID: 5143922
[No Abstract] [Full Text] [Related]
12. Ethionamide+cycloserine+pas vs isoniazid+streptomycin+pas in initial antiburerculosis chemotherapy followed by the standard regimen. A controlled study with special reference to the microscopic enumeration of bacillia as a criterion of efficacy.
Pneumonologie; 1975; 151(3):167-84. PubMed ID: 1187376
[No Abstract] [Full Text] [Related]
13. Cycloserine in the treatment of pulmonary tuberculosis.
Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C
Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
Mamolat AS; Bialik IB
Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969
[No Abstract] [Full Text] [Related]
16. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
[No Abstract] [Full Text] [Related]
17. The tate of patients with drug-resistant tubercle bacilli and pulmonary tuberculosis.
PINES A
Br J Dis Chest; 1962 Oct; 56():163-70. PubMed ID: 13943667
[No Abstract] [Full Text] [Related]
18. Retreatment of drug resistant tuberculosis at Battey State Hospital.
Corpe RF; Blalock FA
Dis Chest; 1965 Sep; 48(3):305-10. PubMed ID: 5830645
[No Abstract] [Full Text] [Related]
19. Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs.
Horsfall PA
Tubercle; 1972 Sep; 53(3):166-73. PubMed ID: 4116994
[No Abstract] [Full Text] [Related]
20. Isoxyl: a review of the results of its use over a five-year period in the tuberculosis field service of a large urban area.
Gallen CS
Antibiot Chemother; 1970; 16():139-48. PubMed ID: 5535610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
